Advertisement
Screener

SELLAS Life Sciences Group, Inc. (SLS) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

1.5 / 5 stars · 20/67 Roast Me

SELLAS Life Sciences Group, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

SELLAS Life Sciences Group, Inc. (SLS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-11

  • SELLAS Life Sciences Group, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 0.00 shares.
  • SELLAS Life Sciences Group, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 0.00 shares, a 100.00% decline year-over-year.
  • SELLAS Life Sciences Group, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares.
  • SELLAS Life Sciences Group, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares.
  • SELLAS Life Sciences Group, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 817.00K shares, a 21.76% increase from fiscal 2024.
  • SELLAS Life Sciences Group, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 671.00K shares, a 1.61% decline from fiscal 2023.
  • SELLAS Life Sciences Group, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 682.00K shares, a 24.91% increase from fiscal 2022.
  • SELLAS Life Sciences Group, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 546.00K shares, a 67.48% increase from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed
2026-06-300.00 shares
10-Q · filed 2026-08-11
0.00 shares
10-Q · filed 2026-08-11
0.00 shares
derived: sum of 3 quarters · filed 2026-08-11
0.00 shares
derived: sum of 4 quarters · filed 2026-08-11
2026-03-310.00 shares
10-Q · filed 2026-05-12
0.00 shares
derived: sum of 2 quarters · filed 2026-05-12
0.00 shares
derived: sum of 3 quarters · filed 2026-05-12
0.00 shares
derived: sum of 4 quarters · filed 2026-08-11
2025-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19
0.00 shares
derived: sum of 2 quarters · filed 2026-03-19
0.00 shares
derived: sum of 3 quarters · filed 2026-08-11
817.00K shares
10-K · filed 2026-03-19
2025-09-300.00 shares
10-Q · filed 2025-11-12
0.00 shares
derived: sum of 2 quarters · filed 2026-08-11
817.00K shares
10-Q · filed 2025-11-12
817.00K shares
derived: sum of 4 quarters · filed 2026-08-11
2025-06-300.00 shares
10-Q · filed 2026-08-11
817.00K shares
10-Q · filed 2025-08-12
817.00K shares
derived: sum of 3 quarters · filed 2026-08-11
817.00K shares
derived: sum of 4 quarters · filed 2026-08-11
2025-03-31817.00K shares
10-Q · filed 2025-05-13
817.00K shares
derived: sum of 2 quarters · filed 2026-03-19
817.00K shares
derived: sum of 3 quarters · filed 2026-03-19
817.00K shares
derived: sum of 4 quarters · filed 2026-03-19
2024-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19
0.00 shares
derived: sum of 2 quarters · filed 2026-03-19
0.00 shares
derived: sum of 3 quarters · filed 2026-03-19
671.00K shares
10-K · filed 2026-03-19
2024-09-300.00 shares
10-Q · filed 2025-11-12
0.00 shares
derived: sum of 2 quarters · filed 2025-11-12
671.00K shares
10-Q · filed 2024-11-13
671.00K shares
derived: sum of 4 quarters · filed 2025-11-12
2024-06-300.00 shares
10-Q · filed 2025-08-12
671.00K shares
10-Q · filed 2024-08-13
671.00K shares
derived: sum of 3 quarters · filed 2025-08-12
671.00K shares
derived: sum of 4 quarters · filed 2025-08-12
2024-03-31671.00K shares
10-Q · filed 2024-05-14
671.00K shares
derived: sum of 2 quarters · filed 2025-03-20
671.00K shares
derived: sum of 3 quarters · filed 2025-03-20
705.00K shares
derived: sum of 4 quarters · filed 2025-03-20
2023-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20
0.00 shares
derived: sum of 2 quarters · filed 2025-03-20
34.00K shares
derived: sum of 3 quarters · filed 2025-03-20
682.00K shares
10-K · filed 2025-03-20
2023-09-300.00 shares
10-Q · filed 2024-11-13
34.00K shares
derived: sum of 2 quarters · filed 2024-11-13
682.00K shares
10-Q · filed 2023-11-09
685.00K shares
derived: sum of 4 quarters · filed 2024-11-13
2023-06-3034.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
682.00K shares
10-Q · filed 2023-08-10
685.00K shares
derived: sum of 3 quarters · filed 2024-03-28
750.00K shares
derived: sum of 4 quarters · filed 2024-03-28
2023-03-31648.00K shares
10-Q · filed 2023-05-11
651.00K shares
derived: sum of 2 quarters · filed 2024-03-28
716.00K shares
derived: sum of 3 quarters · filed 2024-03-28
722.00K shares
derived: sum of 4 quarters · filed 2024-03-28
2022-12-313.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
68.00K shares
derived: sum of 2 quarters · filed 2024-03-28
74.00K shares
derived: sum of 3 quarters · filed 2024-03-28
546.00K shares
10-K · filed 2024-03-28
2022-09-3065.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
71.00K shares
derived: sum of 2 quarters · filed 2022-11-14
543.00K shares
10-Q · filed 2022-11-14
551.00K shares
derived: sum of 4 quarters · filed 2023-03-16
2022-06-306.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
478.00K shares
10-Q · filed 2022-08-11
486.00K shares
derived: sum of 3 quarters · filed 2023-03-16
492.00K shares
derived: sum of 4 quarters · filed 2023-03-16
2022-03-31472.00K shares
10-Q · filed 2022-05-12
480.00K shares
derived: sum of 2 quarters · filed 2023-03-16
486.00K shares
derived: sum of 3 quarters · filed 2023-03-16
520.00K shares
derived: sum of 4 quarters · filed 2023-03-16
2021-12-318.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
14.00K shares
derived: sum of 2 quarters · filed 2023-03-16
48.00K shares
derived: sum of 3 quarters · filed 2023-03-16
326.00K shares
10-K · filed 2023-03-16
2021-09-306.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
40.00K shares
derived: sum of 2 quarters · filed 2021-11-12
318.00K shares
10-Q · filed 2021-11-12
318.00K shares
derived: sum of 4 quarters · filed 2022-03-31
2021-06-3034.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
312.00K shares
10-Q · filed 2021-08-12
312.00K shares
derived: sum of 3 quarters · filed 2022-03-31
312.00K shares
derived: sum of 4 quarters · filed 2022-03-31
2021-03-31278.00K shares
10-Q · filed 2021-05-13
278.00K shares
derived: sum of 2 quarters · filed 2022-03-31
278.00K shares
derived: sum of 3 quarters · filed 2022-03-31
292.00K shares
derived: sum of 4 quarters · filed 2022-03-31
2020-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31
0.00 shares
derived: sum of 2 quarters · filed 2022-03-31
14.00K shares
derived: sum of 3 quarters · filed 2022-03-31
186.00K shares
10-K · filed 2022-03-31
2020-09-300.00 shares
10-Q · filed 2021-11-12
14.00K shares
derived: sum of 2 quarters · filed 2021-11-12
186.00K shares
10-Q · filed 2020-11-13
186.20K shares
derived: sum of 4 quarters · filed 2021-11-12
2020-06-3014.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13
186.00K shares
10-Q · filed 2020-08-13
186.20K shares
derived: sum of 3 quarters · filed 2021-03-23
186.20K shares
derived: sum of 4 quarters · filed 2021-03-23
2020-03-31172.00K shares
10-Q · filed 2020-05-14
172.20K shares
derived: sum of 2 quarters · filed 2021-03-23
172.20K shares
derived: sum of 3 quarters · filed 2021-03-23
172.20K shares
derived: sum of 4 quarters · filed 2021-03-23
2019-12-31200.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23
200.00 shares
derived: sum of 2 quarters · filed 2021-03-23
200.00 shares
derived: sum of 3 quarters · filed 2021-03-23
19.00K shares
10-K · filed 2021-03-23
18.80K shares
10-K · filed 2020-03-13
2019-09-300.00 shares
10-Q · filed 2019-11-14
0.00 shares
derived: sum of 2 quarters · filed 2019-11-14
18.80K shares
10-Q · filed 2019-11-14
466.65K shares
derived: sum of 4 quarters · filed 2020-03-13
2019-06-300.00 shares
10-Q · filed 2019-08-14
940.00K shares
10-Q · filed 2019-08-14
466.65K shares
derived: sum of 3 quarters · filed 2020-03-13
466.65K shares
derived: sum of 4 quarters · filed 2020-03-13
2019-03-31940.00K shares
10-Q · filed 2019-05-15
466.65K shares
derived: sum of 2 quarters · filed 2020-03-13
466.65K shares
derived: sum of 3 quarters · filed 2020-03-13
544.65K shares
derived: sum of 4 quarters · filed 2020-03-13
2018-12-31-473.35K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13
-473.35K shares
derived: sum of 2 quarters · filed 2020-03-13
-395.35K shares
derived: sum of 3 quarters · filed 2020-03-13
9.65K shares
10-K · filed 2020-03-13
483.00K shares
10-K · filed 2019-03-22
2018-09-300.00 shares
10-Q · filed 2019-11-14
78.00K shares
derived: sum of 2 quarters · filed 2019-11-14
483.00K shares
10-Q · filed 2018-11-14
388.00K shares
derived: sum of 4 quarters · filed 2019-11-14
2018-06-3078.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14
483.00K shares
10-Q · filed 2018-08-14
388.00K shares
derived: sum of 3 quarters · filed 2018-08-14
388.00K shares
derived: sum of 4 quarters · filed 2018-08-14
2018-03-31405.00K shares
10-Q · filed 2018-05-15
310.00K shares
derived: sum of 2 quarters · filed 2018-05-15
310.00K shares
derived: sum of 3 quarters · filed 2018-05-15
345.00K shares
derived: sum of 4 quarters · filed 2018-05-15
2017-12-31-95.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-13
-95.00K shares
derived: sum of 2 quarters · filed 2018-04-13
-60.00K shares
derived: sum of 3 quarters · filed 2018-04-13
10.00K shares
10-K · filed 2018-04-13
2017-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
35.00K shares
derived: sum of 2 quarters · filed 2017-11-09
105.00K shares
10-Q · filed 2017-11-09
-1.11M shares
derived: sum of 4 quarters · filed 2018-04-13
2017-06-3035.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
105.00K shares
10-Q · filed 2017-08-14
-1.11M shares
derived: sum of 3 quarters · filed 2018-04-13
-6.00K shares
derived: sum of 4 quarters · filed 2018-04-13
2017-03-3170.00K shares
10-Q · filed 2017-05-10
-1.14M shares
derived: sum of 2 quarters · filed 2018-04-13
-41.00K shares
derived: sum of 3 quarters · filed 2018-04-13
20.00K shares
derived: sum of 4 quarters · filed 2018-04-13
2016-12-31-1.21M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-13
-111.00K shares
derived: sum of 2 quarters · filed 2018-04-13
-50.00K shares
derived: sum of 3 quarters · filed 2018-04-13
55.00K shares
10-K · filed 2018-04-13
146.00K shares
10-K · filed 2017-03-15
2016-09-301.10M shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
1.16M shares
derived: sum of 2 quarters · filed 2016-11-09
1.27M shares
10-Q · filed 2016-11-09
4.33M shares
derived: sum of 4 quarters · filed 2016-11-09
2016-06-3061.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
166.00K shares
10-Q · filed 2016-08-09
3.23M shares
derived: sum of 3 quarters · filed 2016-08-09
3.23M shares
derived: sum of 4 quarters · filed 2016-08-09
2016-03-31105.00K shares
10-Q · filed 2016-05-10
3.17M shares
derived: sum of 2 quarters · filed 2016-05-10
3.17M shares
derived: sum of 3 quarters · filed 2016-05-10
4.42M shares
derived: sum of 4 quarters · filed 2016-05-10
2015-12-313.06M shares
derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-04-15
3.06M shares
derived: sum of 2 quarters · filed 2016-04-15
4.31M shares
derived: sum of 3 quarters · filed 2016-04-15
6.74M shares
10-K/A · filed 2016-04-15
2015-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
1.25M shares
derived: sum of 2 quarters · filed 2015-11-09
3.68M shares
10-Q · filed 2015-11-09
3.82M shares
derived: sum of 4 quarters · filed 2015-12-04
2015-06-301.25M shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
3.68M shares
10-Q · filed 2015-08-06
3.82M shares
derived: sum of 3 quarters · filed 2015-12-04
4.22M shares
derived: sum of 4 quarters · filed 2015-12-04
2015-03-312.43M shares
10-Q · filed 2015-05-07
2.57M shares
derived: sum of 2 quarters · filed 2015-12-04
2.97M shares
derived: sum of 3 quarters · filed 2015-12-04
3.73M shares
derived: sum of 4 quarters · filed 2015-12-04
2014-12-31140.00K shares
derived: 8-K 12 month − 10-Q 9 month · filed 2015-12-04
540.00K shares
derived: sum of 2 quarters · filed 2015-12-04
1.29M shares
derived: sum of 3 quarters · filed 2015-12-04
1.38M shares
8-K · filed 2015-12-04
2014-09-30400.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05
1.16M shares
derived: sum of 2 quarters · filed 2014-11-05
1.24M shares
10-Q · filed 2014-11-05
5.57M shares
derived: sum of 4 quarters · filed 2014-11-05
2014-06-30755.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11
835.00K shares
10-Q · filed 2014-08-11
5.17M shares
derived: sum of 3 quarters · filed 2014-08-11
5.17M shares
derived: sum of 4 quarters · filed 2014-08-11
2014-03-3180.00K shares
10-Q · filed 2014-05-06
4.41M shares
derived: sum of 2 quarters · filed 2014-05-06
4.41M shares
derived: sum of 3 quarters · filed 2014-05-06
5.12M shares
derived: sum of 4 quarters · filed 2014-05-06
2013-12-314.33M shares
derived: 10-K 12 month − 10-Q/A 9 month · filed 2014-03-17
4.33M shares
derived: sum of 2 quarters · filed 2014-03-17
5.04M shares
derived: sum of 3 quarters · filed 2014-03-17
7.11M shares
10-K · filed 2014-03-17
2013-09-300.00 shares
derived: 10-Q/A 9 month − 10-Q 6 month · filed 2013-11-07
710.00K shares
derived: sum of 2 quarters · filed 2013-11-07
2.78M shares
10-Q/A · filed 2013-11-07
2.93M shares
derived: sum of 4 quarters · filed 2013-11-07
2013-06-30710.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09
2.78M shares
10-Q · filed 2013-08-09
2.93M shares
derived: sum of 3 quarters · filed 2013-08-09
3.11M shares
derived: sum of 4 quarters · filed 2013-08-09
2013-03-312.07M shares
10-Q · filed 2013-05-09
2.22M shares
derived: sum of 2 quarters · filed 2013-05-09
2.40M shares
derived: sum of 3 quarters · filed 2013-05-09
2012-12-31150.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12
325.00K shares
derived: sum of 2 quarters · filed 2013-03-12
1.80M shares
10-K · filed 2013-03-12
2012-09-30175.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13
1.65M shares
10-Q · filed 2012-11-13
2012-06-301.48M shares
10-Q · filed 2012-08-14
2011-12-313.32M shares
10-K · filed 2013-03-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
uniQure N.V. (QURE)$2.416B-4.93
Vera Therapeutics, Inc. (VERA)United States$2.402B-7.67
Harmony Biosciences Holdings, Inc. (HRMY)United States$2.399B11.67
Nurix Therapeutics, Inc. (NRIX)United States$2.457B-5.39
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38
SUPERNUS PHARMACEUTICALS, INC. (SUPN)United States$2.517B-24.63
Immunome Inc. (IMNM)United States$2.538B-9.45
Disc Medicine, Inc. (IRON)United States$2.553B-11.40
Zai Lab Ltd (ZLAB)$2.241B-113.34